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BARRETT INSTALLED AS PRESIDENT;
SHPALL ELECTED VICE PRESIDENT
A. John Barrett, MD, has been in-
stalled as president of the American
Society for Blood and Marrow Trans-
plantation. He is section chief for
stem cell allotransplantation in the He-
matology Branch of the NIH National
Heart Lung and Blood Institute, Be-
thesda, MD.
Elizabeth J. Shpall, MD, the Ashbel
Smith Professor of Medicine at the Uni-
versity of Texas MD Anderson Cancer
Center, is the newly elected and in-
stalled vice president, to become pres-
ident in 2012. She is also the cancer
center’s Cell Therapy Laboratory med-
ical director and the Cord Blood Bank
director.
The installation of new officers and
directors occurred at the society’s an-
nual meeting, the BMT Tandem Meet-
ings, on Feb. 26 in Orlando. The
election was by ballot among mem-
bers of the society in December and
January.
Newly elected and installed direc-
tors are:
Linda J. Burns, MD, of the Univer-
sity of Minnesota Medical School
in Minneapolis, MN
Peter A. McSweeney, MD, of the
Rocky Mountain Blood and Mar-
row Transplant Program in Denver,
CO
Warren D. Shlomchik, MD, of the
Yale University School of Medicine
in New Haven, CT
All took office at the close of the
BMT Tandem Meetings.
Daniel J. Weisdorf, MD, was ele-
vated to president-elect and will as-
sume the presidency in 2011. He is
professor of medicine at the University
of Minnesota in Minneapolis, the di-
rector of the University of Minnesota’s
Adult Blood and Marrow Transplant
Program, and is scientific director for
the National Marrow Donor Program
and senior research advisor for the
CIBMTR.The new ASBMT president, Dr. Bar-
rett, trained at St Bartholomew’s
Hospital London in 1968, and special-
ized in hematology and stem cell
transplantation, studying in London
and Paris. In 1982 he was appointed
Professor of Hematology at Charing
Cross and Westminster Medical
School, and from 1988 at the Ham-
mersmith Hospital, London. Since
1993 he has served at the NIH in Be-
thesda, MD, as Chief of the National
Heart, Lung and Blood Institute’s
Bone Marrow Stem Cell Allotransplan-
tation Section in the Hematology
Branch.
Dr. Barrett has been a member of
the ASBMT since its foundation. He
has a long association with the
CIBMTR, as a Member of the Advisory
Committee, Councilor, Member of the
Executive Committee, Co-Chairman
of the GVHD-GVL Working Commit-
tee and Scientific Program chair
2007. He is a member of the Interna-
tional Society for Cellular Therapy
and senior editor of their journal Cyto-
therapy. He is also a member of the
European Bone Marrow Transplanta-
tion Group and was EBMT president
between 1983-1985.TWO NEW INVESTIGATORS WIN BBMT
EDITORIAL AWARDS
Two medical scientists are the recip-
ients of editorial awards for new inves-
tigators for their articles published this
past year in Biology of Blood and Mar-
row Transplantation.
Both are recipients of a $5,000
prize, supported by grants from Stem-
Cell Technologies Inc., and StemSoft
Software Inc. Selection of the winning
articles was by the BBMT Editorial
Board and the ASBMT Publications
Committee.
Veronika Bachanova, MD, of the
University of Minnesota, in Minneapo-
lis is the winner of the Ernest McCul-
loch & James Till Award for best
basic science article by a new investi-
gator. The award is supported by aneducation grant from StemCell Tech-
nologies Inc.
Her article published in the in the
February 2009 was ‘‘Activated Notch
Supports Development of Cytokine
Producing NK Cells Which Are Hypo-
responsive and Fail to Acquire NK
Cell Effector Functions.’’
Cristina Fondi, MD, of the University
of Florence, in Florence, Italy, is recip-
ient of the George Santos Award for
best clinical science article by a new in-
vestigator. The award is supported by
an education grant from StemSoft
Software Inc.
Her article, published in the August
2009 issue was ‘‘Increase in FOXP3+
Regulatory T Cells in GVHD Skin Biop-
sies is Associated with Lower Disease
Severity and Treatment Response.’’
The awards were presented by
BBMT Editor-in-Chief Robert Korn-
gold, PhD, and representatives of
StemSoft Software and StemCell Tech-
nologies.
The awards were presented at the
2010 BMT Tandem Meetings in Or-
lando.
LIFETIME ACHIEVEMENT AWARD GIVEN
TO JON J. VAN ROOD
The 2010 recipient of the ASBMT Life-
time Achievement Award is Jon J. van
Rood. Dr. van Rood was recognized
for his pioneering work in the field of
human leukocyte antigens (HLA).
The ASBMT Lifetime Achievement
Award is supported by Pfizer Inc.
SIX ABSTRACTS CHOSEN AS BEST OF
2010 BMT TANDEM MEETINGS
A total 498 abstracts from 35 coun-
tries were accepted for the 2010 BMT
Tandem Meetings.
Six of the abstracts were selected
for awards by the abstract review
committees.
Recipients of the ASBMT Best Ab-
stract Awards for Basic Science
Research were:
 Denise Kellar, MD, M.D. Anderson
Cancer Center – CD56+ T Cells707
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meric Antigen Receptor Can Target
CD56+ Malignancies without Au-
tolysis
 Daniel Kraft, Stanford University –
Identification of a Clonogenic Os-
teochondral Skeletal Progenitor
which Forms the Functional Hema-
topoietic Stem Cell Niche
 Yanling Liao, PhD, Columbia Uni-
versity Morgan Stanley Children’s
Hospital – Derivation and Expan-
sion of Neural Stem Cell (NSC) Like
Cells from Human Umbilical Cord
Blood (HUCB)
Each received a $1,000 prize. The
Basic Science Research awards aresupported by a grant from Histoge-
netics, Inc.
Recipients of the CIBMTR Best Ab-
stract Awards for Clinical Research
were:
 Yoshiko Atuska, MD, Nagoya Uni-
versity Graduate School of Medi-
cine – Comparison of Unrelated
Cord Blood Transplantation and
Human Leukocyte Antigen Mis-
matched Unrelated Bone Marrow
Transplantation for Adult Patients
with Hematological Malignancy
 Sophie Paczesny, MD, PhD, Univer-
sity of Michigan – Frequency of
CD4+CD25highFoxP3+ Regula-
tory T Cells has Diagnostic andPrognostic Value as a Biomarker
for Acute Graft-Versus-Host Disease
 Patrick Stiff, MD, Loyola University
Medical Center – A Prospective,
Randomized Double-Blind Phase
III Trial of Aprepitant vs. Placebo
Plus Oral Ondansetron and Dexa-
methasone for the Prevention of
Nausea and Vomiting (N/V) Associ-
ated with Highly Emetogenic Pre-
parative Regimens Prior to
Hematopoietic Stem Cell Trans-
plantation (HSCT)
Each also received a $1,000 prize.
The clinical research awards are sup-
ported by a grant from WellPoint,
Inc.
